Popular Articles

HIV Testing Can Save Thousands Of Lives, CDC Official Says
"Although HIV/AIDS continues to pose a serious threat to the nation"s health, HIV testing is a powerful weapon against the disease," Kevin Fenton, director of CDC"s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, writes in a CNN.com opinion piece. Fenton writes that every 9 1/2 minutes someone in the U.S. becomes infected with HIV. "That"s 56,000 people every year," Fenton writes, adding, "But there"s something we can all do to help protect ourselves and our partners from this disease - get tested for HIV." He continues, "By increasing the number of people who know their HIV status, we can decrease the number of new HIV infections, and help save thousands of lives" (Fenton, CNN.com, 6/26).

Funding For Research On The H1N1 Flu Virus Announced By Government Of Canada
The Honourable Leona Aglukkaq, Minister of Health, is pleased to announce another measure to address the H1N1 flu virus. The Government of Canada will fund a national influenza research network focused on pandemic vaccine evaluation. The network will strengthen Canada"s capacity to evaluate the safety and effectiveness of a pandemic influenza vaccine and vaccination programs.
News of the day
AMSA Avant Research Bursary Winners And Applications For 2010
Congratulations to the winners of the 2009 Avant/AMSA Student Research Fellowship:
Medical Devices

UT Gets Federal Stimulus Grant For Parkinson's Disease Research

The University of Texas Health Science Center at Houston has received a $412,500 federal stimulus grant for Parkinson"s disease research, the university announced today. It is the university"s first federal stimulus grant. Parkinson"s disease is an incurable brain disorder. Its symptoms include trembling, stiffness and problems with balance. An estimated one million Americans are diagnosed with the neurological disorder. The two-year grant will support efforts by researchers in the university"s Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) to develop a therapeutic vaccine. Rowen Chang, Ph.D, an IMM professor of protein chemistry, is the principal investigator on the grant that comes from The National Institute of Neurological Disorders and Stroke through the American Recovery and Reinvestment Act of 2009. Chuantao Jiang, M.D., Ph.D., an assistant research professor at the IMM, is co-principal investigator. Chang plans to add one or two researchers to the team of scientists in his lab with the funds. The grant extends through April 30, 2011. "We are excited about receiving this grant, which will support our research and help the economy by employing more scientists," Chang said. Chang believes he may be able to slow the progression of Parkinson"s disease and possibly even prevent it by targeting a protein associated with the disease called alpha-synuclein. If successful, Chang"s vaccine would work by strengthening the immune system"s ability to suppress the activity of alpha-synuclein through the production of antibodies. The effectiveness of this vaccine will be tested in transgenic mice expressing human alpha-synuclein. The American Recovery and Reinvestment Act was passed by Congress to jumpstart the economy and create jobs. "The focus of the research has been on creating "locked structures" of proteins by internal cross linking," said C. Thomas Caskey, M.D., IMM Director/CEO. "The application of this technology to creation of therapeutic antibodies for Parkinson"s disease is a creative approach to new therapies for a challenging disease." Chang has been on the faculty of the Institute of Molecular Medicine for about a decade and was one of the initial appointments. He obtained his master"s of science degree from the National Taiwan University in Taipei and his doctorate from the Australian National University at Canberra. Robert Cahill University of Texas Health Science Center at Houston


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):